Processa Pharmaceuticals (PCSA) Inventory (2012 - 2015)
Processa Pharmaceuticals' (PCSA) quarterly Inventory came in at $141484.0 in Q3 2015, down 29.52% YoY from $200751.0 in Q3 2014, and down 30.38% on a QoQ basis from $203230.0 in Q2 2015.
Processa Pharmaceuticals (PCSA) Inventory (2012 - 2015) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 4 years of Inventory data on file, last reported at $141484.0 in Q3 2015.
- Quarterly Inventory fell 29.52% year-over-year to $141484.0 in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $141484.0 (down 29.52% YoY) and the FY2014 annual result came in at $219203.0, down 3.97% from the prior year.
- Inventory retreated to $141484.0 in Q3 2015, from $203230.0 in the prior quarter.
- In the past five years, Inventory ranged from a high of $263780.0 in Q1 2014 to a low of $48749.0 in Q4 2012.
- A 4-year average of $192202.9 and a median of $203230.0 in 2015 frame the typical range for Inventory.
- Annual changes were most pronounced in 2013 — Inventory jumped 368.23% — and 2015, when it slipped 29.52%.
- Tracing PCSA's Inventory over 4 years: stood at $48749.0 in 2012, then surged by 368.23% to $228256.0 in 2013, then declined by 3.97% to $219203.0 in 2014, then plunged by 35.46% to $141484.0 in 2015.
- The last three Inventory figures came in at $141484.0 (Q3 2015), $203230.0 (Q2 2015), and $197129.0 (Q1 2015), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.25 Bn | 131.40 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.31 Bn | 992.69 Mn | 97.11 Mn |
| 7 | BioNTech SE | 28.03 Bn | 9.63 Bn | 668.28 Mn | 128.86 Mn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | 142.38 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | - |
| 10 | Processa Pharmaceuticals | 5.72 Mn | 5.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 141,484.00 |
| Jun 30, 2015 | 203,230.00 |
| Mar 31, 2015 | 197,129.00 |
| Dec 31, 2014 | 219,203.00 |
| Sep 30, 2014 | 200,751.00 |
| Jun 30, 2014 | 206,277.00 |
| Mar 31, 2014 | 263,780.00 |
| Dec 31, 2013 | 228,256.00 |
| Sep 30, 2013 | 207,001.00 |
| Jun 30, 2013 | 198,372.00 |
| Dec 31, 2012 | 48,749.00 |